We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+13.42%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$259M
AUM Growth
-$89.4M
Cap. Flow
-$130M
Cap. Flow %
-50.25%
Top 10 Hldgs %
30.79%
Holding
94
New
15
Increased
16
Reduced
26
Closed
29

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$8.83M
2
MLM icon
Martin Marietta Materials
MLM
+$4.82M
3
ASIX icon
AdvanSix
ASIX
+$4.5M
4
ELV icon
Elevance Health
ELV
+$3.51M
5
BLUE
bluebird bio
BLUE
+$2.9M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$17.8M
2
ALGN icon
Align Technology
ALGN
+$7.72M
3
LOXO
Loxo Oncology, Inc
LOXO
+$4.14M
4
TLND
Talend S.A. American Depositary Shares
TLND
+$4.09M
5
ALB icon
Albemarle
ALB
+$3.95M

Sector Composition

Rank Sector Weight
1 Healthcare 32.38%
2 Technology 17.21%
3 Communication Services 14.84%
4 Consumer Discretionary 6.43%
5 Financials 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAL icon
26
American Airlines Group
AAL
$9.82B
$4.11M 1.59%
79,000
-11,000
-12% -$548K
ICUI icon
27
ICU Medical
ICUI
$4.16B
$4.1M 1.59%
19,000
+3,000
+19% +$607K
AMZN icon
28
Amazon
AMZN
$2.44T
$4.09M 1.58%
70,000
-2,000
-3% -$110K
GWPH
29
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.09M 1.58%
31,000
-1,500
-5% -$176K
AERI
30
DELISTED
Aerie Pharmaceuticals
AERI
$3.92M 1.52%
65,600
+8,600
+15% +$522K
BMY icon
31
CALL
Bristol-Myers Squibb
BMY
$129B
$3.9M 1.51%
63,700
+13,700
+27% +$857K
ELV icon
32
Elevance Health
ELV
$81.5B
$3.71M 1.44%
+16,500
New +$3.51M
ESPR
33
DELISTED
Esperion Therapeutics
ESPR
$3.69M 1.43%
56,000
+42,300
+309% +$2.28M
ROKU icon
34
Roku
ROKU
$21.6B
$3.52M 1.36%
68,000
-4,000
-6% -$138K
PTLA
35
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.41M 1.32%
70,000
+12,000
+21% +$607K
EXAS
36
DELISTED
Exact Sciences
EXAS
$3.31M 1.28%
63,000
-27,000
-30% -$1.44M
AIMT
37
DELISTED
Aimmune Therapeutics
AIMT
$3.21M 1.24%
+85,000
New +$2.74M
ALNY icon
38
Alnylam Pharmaceuticals
ALNY
$38.3B
$3.18M 1.23%
25,000
– –
MZOR
39
DELISTED
Mazor Robotics Ltd.
MZOR
$3.1M 1.2%
60,000
-27,000
-31% -$1.52M
MTN icon
40
Vail Resorts
MTN
$5.7B
$2.93M 1.13%
13,800
-200
-1% -$44.8K
RHT
41
DELISTED
Red Hat Inc
RHT
$2.88M 1.11%
24,000
-1,000
-4% -$123K
O icon
42
PUT
Realty Income
O
$61.1B
$2.85M 1.1%
+51,600
New +$2.8M
LUV icon
43
Southwest Airlines
LUV
$21.7B
$2.75M 1.06%
+42,000
New +$2.47M
SIEN
44
DELISTED
Sientra, Inc.
SIEN
$2.59M 1%
18,400
-3,600
-16% -$523K
MCD icon
45
McDonald's
MCD
$193B
$2.58M 1%
15,000
-5,000
-25% -$840K
HDB icon
46
HDFC Bank
HDB
$123B
$2.54M 0.98%
100,000
-28,000
-22% -$670K
SGI
47
Somnigroup International
SGI
$14.4B
$2.51M 0.97%
160,000
-140,000
-47% -$2.14M
INGN icon
48
Inogen
INGN
$174M
$2.5M 0.97%
21,000
-27,946
-57% -$3.08M
DAL icon
49
Delta Air Lines
DAL
$56.7B
$2.24M 0.87%
+40,000
New +$2.09M
TTWO icon
50
PUT
Take-Two Interactive
TTWO
$46.1B
$2.2M 0.85%
+20,000
New +$2.18M
1
2
3 4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Atika Capital Management held 94 positions worth $259M, down 26% from $348M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Atika Capital Management withdrew a net $130M in Q4 2017, closing 29 positions and reducing 26 holdings. Its most notable exit was Loxo Oncology, Inc, an estimated $4.14M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Atika Capital Management opened a new position in Goldman Sachs worth $9.17M.

  • Atika Capital Management's largest Q4 2017 buy was Goldman Sachs: 36,000 shares worth $9.17M.
  • Atika Capital Management added most to Martin Marietta Materials in Q4 2017, an estimated $4.82M increase.
  • Atika Capital Management's biggest Q4 2017 reduction was Intuitive Surgical, cutting an estimated $17.8M.
  • Atika Capital Management fully exited Loxo Oncology, Inc in Q4 2017, selling an estimated $4.14M.
  • Atika Capital Management's ten largest holdings make up 31% of its $259M portfolio in Q4 2017.
  • Atika Capital Management opened 15 new positions and closed 29 in Q4 2017.
  • Atika Capital Management's portfolio value fell 26% quarter-over-quarter to $259M.

Based on Atika Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.